prolonged release dosage form comprising oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof in the treatment of bladder pain syndrome (bps)
The present invention provides a pharmaceutical dosage form comprising oxycodone and naloxone (or pharmaceutically acceptable salts thereof) for use in the treatment of bladder pain syndrome (bps) and / or at least one, preferably at least two of its symptoms.a presente invenção fornece uma forma de dosagem farmacêutica compreendendo oxicodona e naloxona (ou seus sais farmaceuticamente aceitáveis) para uso no tratamento da síndrome de dor na bexiga (bps) e/ou ao menos um, de preferência, ao menos dois dos seus sintomas.
